Zeke Capital Advisors’s ResMed RMD Stock Holding History

Zeke Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,003	Closed	-$231K	–	633
2018 Q3	$231K	Hold	2,003	–	–	0.02%	581
2018 Q2	$207K	Buy	+2,003	New	+$203K	0.02%	550

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Zeke Capital Advisors's RMD Position: Q4 2018 in Review

Zeke Capital Advisors sold out of ResMed (RMD) in Q4 2018, closing a stake of 2,003 shares — an estimated $231K sold.

Zeke Capital Advisors first reported a position in RMD in Q2 2018 and held it in 2 quarters. The position peaked at $231K in Q3 2018. 501 funds tracked by Wall St. Rank hold RMD as of Q4 2018.

Zeke Capital Advisors reported no remaining ResMed position as of Q4 2018 after selling out during the quarter.
Zeke Capital Advisors sold 2,003 ResMed shares in Q4 2018, an estimated $231K.
Zeke Capital Advisors first reported a position in ResMed in Q2 2018 and held it in 2 quarters.
Zeke Capital Advisors's ResMed position peaked at $231K in Q3 2018.
501 funds tracked by Wall St. Rank held ResMed as of Q4 2018.

Based on Zeke Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.